Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.

about

Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France.

Item

http://www.wikidata.org/entity/Q49222117

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@en

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@nl

type

Item

label

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@en

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@nl

prefLabel

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@en

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@nl

P1476

Comparison of Paliperidone Pal ...... ective Cohort Study in France.

@en

P2093

Denis Comet

http://www.w3.org/2001/XMLSchema#string

Drifa Belhadi

http://www.w3.org/2001/XMLSchema#string

Frédéric Limosin

http://www.w3.org/2001/XMLSchema#string

Kristel Van Impe

http://www.w3.org/2001/XMLSchema#string

Maud Pacou

http://www.w3.org/2001/XMLSchema#string

Pascal Guillon

http://www.w3.org/2001/XMLSchema#string

Sophie Bouju

http://www.w3.org/2001/XMLSchema#string

P2860

Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database A

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature.

Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness.

Cost of disorders of the brain in Europe.

First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies.

Practical guidelines on the use of paliperidone palmitate in schizophrenia.

Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate.

Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS).

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

P304

19-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/JCP.0000000000000827

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29232310

http://www.w3.org/2001/XMLSchema#string

P921

schizophrenia

P932

5737453

http://www.w3.org/2001/XMLSchema#string